101 Main Street, Floor 14
Tel: 617-712 -1417
About WuXi NextCODEWuXi NextCODE is a fully integrated global contract genomics organization. With offices in Shanghai; Kendall Square in Cambridge, Massachusetts; and Reykjavik, Iceland, we offer comprehensive services that enable population, precision medicine, diagnostics and wellness initiatives and enterprises to use the genome to improve health around the world. Our capabilities span study design, sequencing, secondary analysis, storage, and interpretation and scalable analytics – all backed by the most proven and widely used technology for organizing, mining and sharing genome sequence data. We are also applying the same capabilities to advance a growing range of sequence-based tests and scans in China. WuXi NextCODE is a WuXi AppTec Group company.
Founder and CEO: Hannes Smarason
Founder and CSO: Jeffrey Gulcher
CTO: Hongye Sun
Please click here for WuXi NextCODE job opportunities.
FOLLOW WUXI NEXTCDE:
Tweets by WuXi NextCODE
15 articles with WuXi NextCODE
$400 Million Investment Programme Positions Ireland for Global Leadership in Genomic Research and Advanced Life Sciences
Ireland Strategic Investment Fund and leading global investors back significant expansion of Genomics Medicine Ireland (GMI), creating up to 600 high-value jobs over five years
WuXi NextCODE detailed its plans and progress in building a pioneering global network to improve the diagnosis and treatment of rare disease.
WuXi NextCODE, the emerging global standard platform for genomic data, today announced that CEO Hannes Smarason will present at Cowen and Company's 38th Annual Health Care Conference on Monday, March 12, at 11:30am ET. The conference is being held at the Boston Marriott Copley Place Hotel on March 12-14.
- WuXi NextCODE's massively scalable genomics database management system and clinical and research applications will be available to Google Cloud Platform users - Google Cloud BigQuery, the open source DeepVariant and other tools will be integrated for use with the WuXi NextCODE platform - The companies plan to work on additional tools, capabilities and APIs going forward, to serve the global genomics community for the benefit of people worldwide
Here is a look at the life science companies viewed as the most innovative in the world.
WuXi NextCODE Artificial Intelligence Used to Advance Precision Therapy for Rare Genetic Disorders of Obesity
The first phase of the partnership involved mining WuXi NextCODE's knowledgebase of all major reference datasets to identify all rare sequence variants in the POMC, PCSK1, and LEPR genes in the MC4R pathway.
WuXi NextCODE, the global standard platform for genomic data, today announced the appointment of John Gu as Chief Digital Officer, leading data onboarding for the company's growing China platform.
WuXi NextCODE today announced the first open-access installation of Oxford Nanopore instruments in a CAP/CLIA lab in China at WuXi NextCODE's sequencing laboratory in Shanghai.
WuXi NextCODE At ASHG: Population Genomics, Unleashing Cancer Data, Diagnosing Rare Disease, The Internet Of DNA
WuXi NextCODE, the global standard platform for genomic data, invites attendees at the American Society of Human Genetics annual meeting being held this week in Orlando to visit booth #1031.
WuXi NextCODE AI Points To New Therapeutic Approaches To Cardiovascular Disease And Cancer In Yale Nature Study